Cargando…

Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers

Joint health is a key contributor to quality of life in patients with hemophilia. However, variables that impact long-term joint outcomes have not been comprehensively defined. A systematic literature search identified publications relating to joint health in patients with hemophilia. Studies clearl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gooding, Richard, Thachil, Jecko, Alamelu, Jayanthi, Motwani, Jayashree, Chowdary, Pratima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023018/ https://www.ncbi.nlm.nih.gov/pubmed/33833602 http://dx.doi.org/10.2147/JBM.S304597

Ejemplares similares

Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics
por: Zhou, Jenny Y., et al.
Publicado: (2019)

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia
por: Boccalandro, Elena Anna, et al.
Publicado: (2023)

Bleeding phenotype in nonsevere hemophilia by International Society on Thrombosis and Haemostasis bleeding assessment tool, bleeding frequency, and the joint status
por: Rejtő, Judit, et al.
Publicado: (2023)

Non‐factor therapies for bleeding disorders: A primer for the general haematologist
por: Swan, Dawn, et al.
Publicado: (2022)

DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Diagnostic Values of Inflammatory and Angiogenic Factors for Acute Joint Bleeding in Patients With Severe Hemophilia A
por: Xu, Huijuan, et al.
Publicado: (2020)

Joint status of patients with nonsevere hemophilia A
por: Zwagemaker, Anne‐Fleur, et al.
Publicado: (2022)

Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A
por: Rossbach, Hans-Christoph
Publicado: (2010)

Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate(®)) in hemophilia A
por: Chowdary, Pratima, et al.
Publicado: (2016)

The implications of aspirin resistance in renal failure
por: Thachil, Jecko
Publicado: (2008)

Abnormal coagulation tests before kidney biopsies—what next?
por: Thachil, Jecko
Publicado: (2013)

The difficult distinction between haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura
por: Thachil, Jecko
Publicado: (2008)

Usefulness of Combining D-Dimers with Thromboelastography
por: Thachil, Jecko
Publicado: (2020)

Lessons learnt from COVID‐19 coagulopathy
por: Thachil, Jecko
Publicado: (2021)

Hypoxia—An overlooked trigger for thrombosis in COVID‐19 and other critically ill patients
por: Thachil, Jecko
Publicado: (2020)

The versatile heparin in COVID‐19
por: Thachil, Jecko
Publicado: (2020)

BE EMPOWERED, A Specialty Pharmacy Education Program for Hemophilia B Patients, Impacts Adult Joint Bleeds and Pediatric Use of RICE
por: Blankenship, Crystal S., et al.
Publicado: (2014)

Global coagulation assays in hemophilia A: A comparison to conventional assays
por: Aghighi, Saman, et al.
Publicado: (2019)

Blood-Induced Joint Damage: The Devastating Effects of Acute Joint Bleeds versus Micro-Bleeds
por: van Meegeren, Monique E.R., et al.
Publicado: (2013)

Long‐term joint outcomes in adolescents with moderate or severe haemophilia A
por: Schmidt, David E., et al.
Publicado: (2022)

Uncontrollable bleeding after tooth extraction from asymptomatic mild hemophilia patients: two case reports
por: Fan, Guo, et al.
Publicado: (2022)

Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity
por: Wang, Michael, et al.
Publicado: (2020)

The application of anticoagulant therapy to sepsis
por: Thachil, Jecko, et al.
Publicado: (2017)

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
por: Iba, Toshiaki, et al.
Publicado: (2017)

Differentiating biochemical from clinical heparin resistance in COVID-19
por: Lisman, Ton, et al.
Publicado: (2020)

Approach to the Diagnosis and Classification of Blood Cell Disorders
por: Thachil, Jecko, et al.
Publicado: (2017)

Acquired Hemophilia A with Gastrointestinal Bleeding
por: Park, Narae, et al.
Publicado: (2020)

The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022)

Developing a new scoring scheme for the Hemophilia Joint Health Score 2.1
por: Ribeiro, Tiago, et al.
Publicado: (2019)

The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study
por: St‐Louis, Jean, et al.
Publicado: (2022)

Nonacog beta pegol (N9‐GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients
por: Chan, Anthony K., et al.
Publicado: (2020)

The first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia
por: Stewart, Sarah, et al.
Publicado: (2015)

Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
por: Shapiro, Amy D., et al.
Publicado: (2022)

Correlation between Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score and Hemophilia Joint Health Score (HJHS) in patients with hemophilic arthropathy
por: Prasetyo, Marcel, et al.
Publicado: (2021)

Evaluation of Functional and Joint Health and Associated Factors in Adults With Hemophilia From a Developing Country With Government-Backed Efforts to Improve Hemophilia Care
por: Soares, Beatriz Mac Dowell, et al.
Publicado: (2023)

Prevention and Management of Bleeding Episodes in Children with Hemophilia
por: Ljung, Rolf C. R.
Publicado: (2018)

An Unusual Case of Bleeding: Acquired Hemophilia A
por: Jahangiri, Omeed S, et al.
Publicado: (2023)

The Effect of Aquatic Exercise Therapy on Muscle Strength and Joint's Range of Motion in Hemophilia Patients
por: Kargarfard, Mehdi, et al.
Publicado: (2013)

Perioperative blood loss during joint replacement: comparison between patients with and without hemophilia
por: Yuan, Shanyou, et al.
Publicado: (2022)

Long-term impact of primary prophylaxis on joint status in patients with severe hemophilia A
por: Meijón Ortigueira, María del Mar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ln0jvdigpd4t9ddknrsvi7q81